SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
武雨珍
Lv7
2
3630 积分
2021-08-04 加入
最近求助
最近应助
互助留言
Treatment of factor VII deficiency with recombinant factor VIIa
3天前
已完结
Venetoclax with decitabine or azacitidine in relapsed or refractory acute myeloid leukemia
8天前
已完结
The future paradigm of HMA + VEN or targeted inhibitor approaches: sequencing or triplet combinations in AML therapy
8天前
已关闭
Comparison of venetoclax and ivosidenib/enasidenib for unfit newly diagnosed patients with acute myeloid leukemia and IDH1/2 mutation: a network meta-analysis
8天前
已完结
Fostamatinib for warm antibody autoimmune hemolytic anemia: Phase 3, randomized, double-blind, placebo-controlled, global study (FORWARD)
14天前
已完结
First-Line Venetoclax Combinations in Chronic Lymphocytic Leukemia
1个月前
已完结
First-Line Venetoclax Combinations in Chronic Lymphocytic Leukemia
1个月前
已完结
Re-induction with venetoclax combinations or IDH inhibitors result in similar remission rates and lower treatment related morbidity among AML patients initially receiving intensive induction chemotherapy
1个月前
已完结
Long-term follow-up of VIALE-A: Venetoclax and azacitidine in chemotherapy-ineligible untreated acute myeloid leukemia
1个月前
已完结
Venetoclax plus 3 + 7 daunorubicin and cytarabine chemotherapy as first-line treatment for adults with acute myeloid leukaemia: a multicentre, single-arm, phase 2 trial
1个月前
已完结
没有进行任何应助
感谢,点赞
1天前
感谢,点赞
8天前
点赞,感谢
8天前
感谢,点赞
14天前
感谢,点赞
1个月前
感谢,点赞
1个月前
感谢,点赞
1个月前
感谢,点赞
1个月前
感谢,点赞
1个月前
感谢,点赞
1个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论